Miguel Ángel Ulloa-Miranda, E. Sánchez-Forgach, Fernando Sánchez-Aguirre, Marcelino Hernández-Valencia, D. I. Hernández-Hernández, Miriam Rosas-Luna, Julio Ignacio Ramírez-Gómez
{"title":"遗传性乳腺癌和卵巢癌患者基因突变的发生率","authors":"Miguel Ángel Ulloa-Miranda, E. Sánchez-Forgach, Fernando Sánchez-Aguirre, Marcelino Hernández-Valencia, D. I. Hernández-Hernández, Miriam Rosas-Luna, Julio Ignacio Ramírez-Gómez","doi":"10.24245/gom.v88i2.3427","DOIUrl":null,"url":null,"abstract":"OBJECTIVE: To determine the genetic mutations in hereditary pattern breast cancer and demonstrate whether there is a significant association between the most common in the Mexican population and the risk of suffering it. MATERIALS AND METHODS: Cross-sectional and observational study conducted at the Hospital Angeles México in coordination with the National Institute of Genomic Medicine. Inclusion criteria: patients with breast cancer and one or more first-degree relatives affected by this disease and patients with ovarian cancer. Exclusion criteria: patients without a history of breast or ovarian cancer, or with a family member in the protocol. The RT2 Profiler plate rearrangement technique was used for Master-Mix Quantinova probe PCR kit. The SPSS version 22 program and Epi Info version 7 were used for the statistical analysis. RESULTS: 39 patients with an average age of 53.2 ± 12.1 years were studied. Pro- gesterone and estrogen receptors showed no difference between groups. There was a statistical difference, and CONCLUSION: The data obtained show that in the Mexican population the BRCA2 has a higher incidence in hereditary cancer, at an age of earlier onset and greater nuclear grade at the time of diagnosis.","PeriodicalId":12654,"journal":{"name":"Ginecologia y obstetricia de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Incidencia de mutaciones genéticas en pacientes con cáncer de mama y ovario con patrón de origen hereditario\",\"authors\":\"Miguel Ángel Ulloa-Miranda, E. Sánchez-Forgach, Fernando Sánchez-Aguirre, Marcelino Hernández-Valencia, D. I. Hernández-Hernández, Miriam Rosas-Luna, Julio Ignacio Ramírez-Gómez\",\"doi\":\"10.24245/gom.v88i2.3427\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"OBJECTIVE: To determine the genetic mutations in hereditary pattern breast cancer and demonstrate whether there is a significant association between the most common in the Mexican population and the risk of suffering it. MATERIALS AND METHODS: Cross-sectional and observational study conducted at the Hospital Angeles México in coordination with the National Institute of Genomic Medicine. Inclusion criteria: patients with breast cancer and one or more first-degree relatives affected by this disease and patients with ovarian cancer. Exclusion criteria: patients without a history of breast or ovarian cancer, or with a family member in the protocol. The RT2 Profiler plate rearrangement technique was used for Master-Mix Quantinova probe PCR kit. The SPSS version 22 program and Epi Info version 7 were used for the statistical analysis. RESULTS: 39 patients with an average age of 53.2 ± 12.1 years were studied. Pro- gesterone and estrogen receptors showed no difference between groups. There was a statistical difference, and CONCLUSION: The data obtained show that in the Mexican population the BRCA2 has a higher incidence in hereditary cancer, at an age of earlier onset and greater nuclear grade at the time of diagnosis.\",\"PeriodicalId\":12654,\"journal\":{\"name\":\"Ginecologia y obstetricia de Mexico\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ginecologia y obstetricia de Mexico\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24245/gom.v88i2.3427\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ginecologia y obstetricia de Mexico","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24245/gom.v88i2.3427","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Incidencia de mutaciones genéticas en pacientes con cáncer de mama y ovario con patrón de origen hereditario
OBJECTIVE: To determine the genetic mutations in hereditary pattern breast cancer and demonstrate whether there is a significant association between the most common in the Mexican population and the risk of suffering it. MATERIALS AND METHODS: Cross-sectional and observational study conducted at the Hospital Angeles México in coordination with the National Institute of Genomic Medicine. Inclusion criteria: patients with breast cancer and one or more first-degree relatives affected by this disease and patients with ovarian cancer. Exclusion criteria: patients without a history of breast or ovarian cancer, or with a family member in the protocol. The RT2 Profiler plate rearrangement technique was used for Master-Mix Quantinova probe PCR kit. The SPSS version 22 program and Epi Info version 7 were used for the statistical analysis. RESULTS: 39 patients with an average age of 53.2 ± 12.1 years were studied. Pro- gesterone and estrogen receptors showed no difference between groups. There was a statistical difference, and CONCLUSION: The data obtained show that in the Mexican population the BRCA2 has a higher incidence in hereditary cancer, at an age of earlier onset and greater nuclear grade at the time of diagnosis.